Payers have increasingly implemented a variety cost-containment measures to promote
sustainability in the pharmaceutical sector. This paper provides an assessment of a range of …

Potentially inappropriate prescribing (PIP) is associated with an increased risk of adverse
drug reactions, recognized as a determinant of adherence and increased healthcare costs …

Abstract Background The Stock Visibility System (SVS) is a mobile application and web-
based management tool used at public primary health care (PHC) facilities in South Africa to …

Background Healthcare systems worldwide face escalating pharmaceutical expenditures
despite interventions targeting pricing and generic substitution. Existing studies often …

Biologic drugs represent a large and growing portion of health expenditures. Increasing the
use of biosimilars is a promising option for controlling spending growth in pharmaceutical …

Objectives This study aimed to aid decision makers by analyzing the impact of introducing
biosimilar prescription targets on physician prescribing behavior in the prescription of …

Background We investigate access disparities in pharmaceutical care among German
patients with type 2 diabetes, focusing on differences between public and private health …

Payers are increasingly calling for the value of new drugs to be measured explicitly. We
analyze how the availability of drug quality ratings by health technology assessment (HTA) …

Purpose: Aims to determine the most effective promotional tools putatively influencing
physicians' prescription behavior by examining five commonly-used promotional tools: sales …

Several European administrations have applied various mechanisms promoting cost
containment to stabilise their budgets for pharmaceutical expenditure. Since 2016, Greece …